لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Okeke CAV; Department of Dermatology, Howard University College of Medicine, Washington, DC, USA., Seltzer JA; Department of Dermatology, Howard University College of Medicine, Washington, DC, USA., De Guzman CB; University of California Davis School of Medicine, Sacramento, California, USA., Tran JH; Howard University College of Medicine, Washington, DC, USA., Okoye GA; Department of Dermatology, Howard University College of Medicine, Washington, DC, USA., Byrd AS; Department of Dermatology, Howard University College of Medicine, Washington, DC, USA., Wu PA; Department of Dermatology, University of California Davis School of Medicine, Sacramento, California, USA.

المصدر: Contact dermatitis [Contact Dermatitis] 2024 Aug; Vol. 91 (2), pp. 139-145. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 7604950 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0536 (Electronic) Linking ISSN: 01051873 NLM ISO Abbreviation: Contact Dermatitis Subsets: MEDLINE

مواضيع طبية MeSH: Hair Preparations*/adverse effects , Hair Preparations*/chemistry , Allergens*/adverse effects , Allergens*/analysis , Dermatitis, Allergic Contact*/etiology, Humans ; Betaine/analogs & derivatives ; Betaine/adverse effects ; Betaine/analysis ; Tea Tree Oil/adverse effects ; Tea Tree Oil/analysis ; Perfume/adverse effects ; Perfume/analysis ; Propylene Glycol/adverse effects ; Propylene Glycol/analysis ; Female

المؤلفون: Casas A Jr; Initiative for Maximizing Student Development Program, University of California-San Diego, La Jolla, California, USA Arturo.CasasJr@UTSouthwestern.edu dcauvi@health.ucsd.edu., Hawisher D; Division of Trauma, Critical Care, Burns and Acute Care Surgery, Department of Surgery, School of Medicine, University of California-San Diego, La Jolla, California, USA., De Guzman CB; Division of Trauma, Critical Care, Burns and Acute Care Surgery, Department of Surgery, School of Medicine, University of California-San Diego, La Jolla, California, USA., Bickler SW; Division of Trauma, Critical Care, Burns and Acute Care Surgery, Department of Surgery, School of Medicine, University of California-San Diego, La Jolla, California, USA.; Division of Pediatric Surgery, Rady Children's Hospital, San Diego, California, USA., De Maio A; Initiative for Maximizing Student Development Program, University of California-San Diego, La Jolla, California, USA.; Division of Trauma, Critical Care, Burns and Acute Care Surgery, Department of Surgery, School of Medicine, University of California-San Diego, La Jolla, California, USA.; Department of Neurosciences, School of Medicine, University of California-San Diego, La Jolla, California, USA., Cauvi DM; Division of Trauma, Critical Care, Burns and Acute Care Surgery, Department of Surgery, School of Medicine, University of California-San Diego, La Jolla, California, USA Arturo.CasasJr@UTSouthwestern.edu dcauvi@health.ucsd.edu.

المصدر: Infection and immunity [Infect Immun] 2021 Mar 17; Vol. 89 (4). Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0246127 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-5522 (Electronic) Linking ISSN: 00199567 NLM ISO Abbreviation: Infect Immun Subsets: MEDLINE

مواضيع طبية MeSH: Disease Susceptibility*, Adaptor Proteins, Signal Transducing/*genetics , Adaptor Proteins, Signal Transducing/*metabolism , I-kappa B Proteins/*metabolism , Sepsis/*etiology , Sepsis/*metabolism , Shock, Septic/*etiology , Shock, Septic/*metabolism, Animals ; Animals, Outbred Strains ; Disease Models, Animal ; Lipocalin-2/genetics ; Lipocalin-2/metabolism ; Lipopolysaccharides/adverse effects ; Macrophages/immunology ; Macrophages/metabolism ; Mice ; Sepsis/pathology ; Shock, Septic/pathology

المؤلفون: Deeb LC; Department of Pediatrics, Florida State University College of Medicine, Tallahassee, Florida., Dulude H; Clinical Development, Locemia Solutions, Montreal, Québec, Canada., Guzman CB; Medical Development, Diabetes Business Unit, Formerly Eli Lilly and Company, Indianapolis, Indiana., Zhang S; Statistics, Eli Lilly and Company, Indianapolis, Indiana., Reiner BJ; Clinical Development, Pediatric Endocrine Private Practice, Baltimore, Maryland., Piché CA; Clinical Development, Locemia Solutions, Montreal, Québec, Canada., Pradhan S; Global Scientific Communications, Diabetes Business Unit, Eli Lilly Services India Pvt. Ltd., Bangalore, Karnataka, India., Zhang XM; Medical Development, Diabetes Business Unit, Eli Lilly Canada Inc., Toronto, Ontario, Canada.

المصدر: Pediatric diabetes [Pediatr Diabetes] 2018 Aug; Vol. 19 (5), pp. 1007-1013. Date of Electronic Publication: 2018 Mar 22.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100939345 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-5448 (Electronic) Linking ISSN: 1399543X NLM ISO Abbreviation: Pediatr Diabetes Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 1/*complications , Glucagon/*administration & dosage , Hormones/*administration & dosage , Hypoglycemia/*drug therapy, Administration, Intranasal ; Adolescent ; Caregivers/psychology ; Child ; Diabetes Mellitus, Type 1/drug therapy ; Female ; Humans ; Hypoglycemia/chemically induced ; Insulin/adverse effects ; Male ; Prospective Studies ; Treatment Outcome

المؤلفون: Seaquist ER; University of Minnesota, Minneapolis, Minnesota., Dulude H; Locemia Solutions, Montreal, Québec, Canada., Zhang XM; Medical Development, Diabetes Business Unit, Eli Lilly Canada Inc, Toronto, Ontario, Canada., Rabasa-Lhoret R; Montreal Clinical Research Institute, Montreal, Québec, Canada., Tsoukas GM; McGill University Health Center, Montreal, Québec, Canada., Conway JR; Canadian Centre for Research on Diabetes, Smiths Falls, Ontario, Canada., Weisnagel SJ; CHU de Québec-Université Laval, Quebec City, Québec, Canada., Gerety G; Division of Community Endocrinology, Albany Medical College, Albany, New York., Woo VC; University of Manitoba, Winnipeg, Manitoba, Canada., Zhang S; Statistics, Eli Lilly and Company, Indianapolis, Indiana., Carballo D; Locemia Solutions, Montreal, Québec, Canada., Pradhan S; Global Scientific Communications, Diabetes Business Unit, Eli Lilly Services India Pvt. Ltd, Bangalore, India., Piché CA; Locemia Solutions, Montreal, Québec, Canada., Guzman CB; Medical Development, Diabetes Business Unit, Formerly Eli Lilly and Company, Indianapolis, Indiana.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 May; Vol. 20 (5), pp. 1316-1320. Date of Electronic Publication: 2018 Mar 22.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 1/*drug therapy , Glucagon/*administration & dosage , Hypoglycemia/*drug therapy , Hypoglycemic Agents/*adverse effects , Insulin/*adverse effects, Administration, Intranasal ; Adult ; Blood Glucose/analysis ; Blood Glucose Self-Monitoring ; Caregivers ; Female ; Glucagon/therapeutic use ; Health Knowledge, Attitudes, Practice ; Humans ; Hypoglycemia/blood ; Hypoglycemia/chemically induced ; Hypoglycemia/physiopathology ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Lost to Follow-Up ; Male ; Middle Aged ; Patient Dropouts ; Patient Education as Topic ; Self Report ; Severity of Illness Index ; Syncope/etiology ; Syncope/prevention & control ; Time Factors

المؤلفون: Guzman CB; Eli Lilly and Company Indianapolis IN.; Present address: Enanta Pharmaceuticals Inc Watertown MA., Duvvuru S; Eli Lilly and Company Indianapolis IN.; Present address: Amazon Seattle WA., Akkari A; Cabernet Pharmaceuticals Durham NC., Bhatnagar P; Eli Lilly and Company Indianapolis IN., Battioui C; Eli Lilly and Company Indianapolis IN., Foster W; Eli Lilly and Company Indianapolis IN., Zhang XM; Eli Lilly and Company Toronto Canada., Shankar SS; Eli Lilly and Company Indianapolis IN.; Present address: NGM Biopharmaceuticals San Francisco CA., Deeg MA; Eli Lilly and Company Indianapolis IN.; Present address: Regulus Pharmaceuticals San Diego CA., Chalasani N; Indiana University Department of Medicine Indianapolis IN., Hardy TA; Eli Lilly and Company Indianapolis IN., Kazda CM; Eli Lilly and Company Neuilly sur Seine France., Pillai SG; Eli Lilly and Company Indianapolis IN.

المصدر: Hepatology communications [Hepatol Commun] 2018 Mar 23; Vol. 2 (5), pp. 561-570. Date of Electronic Publication: 2018 Mar 23 (Print Publication: 2018).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: PubMed not MEDLINE

المؤلفون: Guzman CB; Eli Lilly and Company, Indianapolis, Indiana., Dulude H; Locemia Solutions, Montréal, Québec, Canada., Piché C; Locemia Solutions, Montréal, Québec, Canada., Rufiange M; Algorithme Pharma Inc., Montréal, Québec, Canada., Sadoune AA; Algorithme Pharma Inc., Montréal, Québec, Canada., Rampakakis E; JSS Medical Research, Montréal, Québec, Canada., Carballo D; Locemia Solutions, Montréal, Québec, Canada., Triest M; Locemia Solutions, Montréal, Québec, Canada., Zhang MX; Eli Lilly Canada Inc., Toronto, Ontario, Canada., Zhang S; Eli Lilly and Company, Indianapolis, Indiana., Tafreshi M; JSS Medical Research, Montréal, Québec, Canada., Sicard E; Algorithme Pharma Inc., Montréal, Québec, Canada.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Mar; Vol. 20 (3), pp. 646-653. Date of Electronic Publication: 2017 Nov 19.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Common Cold/*complications , Gastrointestinal Agents/*administration & dosage , Glucagon/*administration & dosage , Nasal Decongestants/*pharmacology, Administration, Intranasal ; Adult ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; Female ; Gastrointestinal Agents/pharmacokinetics ; Gastrointestinal Agents/pharmacology ; Glucagon/pharmacokinetics ; Glucagon/pharmacology ; Healthy Volunteers ; Humans ; Hypoglycemia/drug therapy ; Male ; Nasal Obstruction/complications ; Powders

المؤلفون: Guzman CB; Eli Lilly and Company, Indianapolis, Indiana., Zhang XM; Eli Lilly Canada Inc, Toronto, Ontario, Canada., Liu R; Eli Lilly and Company, Indianapolis, Indiana., Regev A; Eli Lilly and Company, Indianapolis, Indiana., Shankar S; Eli Lilly and Company, Indianapolis, Indiana., Garhyan P; Eli Lilly and Company, Indianapolis, Indiana., Pillai SG; Eli Lilly and Company, Indianapolis, Indiana., Kazda C; Eli Lilly and Company, Neuilly-sur-Seine, France., Chalasani N; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana., Hardy TA; Eli Lilly and Company, Indianapolis, Indiana.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2017 Nov; Vol. 19 (11), pp. 1521-1528. Date of Electronic Publication: 2017 Jun 08.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Biphenyl Compounds/*adverse effects , Diabetes Mellitus, Type 2/*drug therapy , Fatty Liver/*chemically induced , Liver/*drug effects , Liver/*metabolism, Adult ; Aged ; Biphenyl Compounds/therapeutic use ; Diabetes Mellitus, Type 2/complications ; Fatty Liver/pathology ; Female ; Humans ; Hypoglycemia/chemically induced ; Hypoglycemia/pathology ; Lipid Metabolism/drug effects ; Liver/pathology ; Male ; Middle Aged ; Receptors, Glucagon/antagonists & inhibitors